spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  samarium Sm-153 lexidronam 

 HSMN NewsFeed - 12 Nov 2007
Cytogen Announces Executive Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2007
Cytogen Announces New Sales and Marketing Leadership with the Appointment of Stephen A. Ross
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2007
Outcomes Data Continue to Demonstrate Value of Cytogen's PROSTASCINT(R) to Predict Prognosis in Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2007
European Association of Nuclear Medicine Journal Article Reports New Data Regarding Administration of QUADRAMET(R) with Chemotherapy in Hormone Refractory Prostate Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2006
American Cancer Society Journal Article Reports New Data Regarding Repeated Administration of QUADRAMET(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2006
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
Biopharmaceuticals Onoclogy
 HSMN NewsFeed - 18 Sep 2006
Combination of High Dose QUADRAMET(R) and Chemotherapy Shows Promise for Treatment of High-Risk Acute Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2006
Cytogen Launches SOLTAMOX(TM), First Oral Liquid Formulation of Hormonal Therapy for Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jul 2006
Cytogen Announces Initiation of Phase III Study Involving QUADRAMET(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jul 2006
Cytogen Announces Publication of Peer-Reviewed Journal Article on QUADRAMET(R)
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2006
Cytogen Announces Departure of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2006
Cytogen and Philips Demonstrate PROSTASCINT(R) Image Acquisition and Processing Tools That Improve Efficiency and Reduce Imaging Time
Devices Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2006
Data Presented at SNM Meeting Demonstrate New Potential for PROSTASCINT(R) through Advances in Nuclear Medicine Imaging
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2006
Data Presented at SNM Meeting Demonstrate Novel Therapeutic Combinations and Applications for QUADRAMET(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2006
New Study Demonstrates That Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Prostate Cancer Recurrence
Diagnostics Urology Oncology
 HSMN NewsFeed - 22 May 2006
Prostate-Specific Membrane Antigen (PSMA) Expression in Neovasculature Associated with Renal Cell Carcinoma is Characterized
Diagnostics Oncology Urology
 HSMN NewsFeed - 8 May 2006
Cytogen Announces FDA Clears IND for CYT-500, a Monoclonal Antibody for the Treatment of Metastatic Hormone-Refractory Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Apr 2006
Cytogen and Savient Finalize Exclusive Distribution Agreement for SOLTAMOX(TM)
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 27 Feb 2006
Positive Findings from Clinical Studies of QUADRAMET(R) in Prostate Cancer Patients with Metastatic Bone Disease Presented at ASCO Prostate Cancer Symposium
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 31 additional stories matching:
samarium Sm-153 lexidronam
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.